Product Images Erlotinib

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Erlotinib NDC 59651-530 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

erlotinib-fig1 - erlotinib fig1

erlotinib-fig1 - erlotinib fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 150 mg (30 Tablets Carton) - erlotinib fig10

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 150 mg (30 Tablets Carton) - erlotinib fig10

This medication package contains erlotinib tablets, each containing 150mg of the active ingredient. Dosage, administration info and storage instructions are found in the package insert. The tablets are not child-resistant. The medication is distributed by Aurobindo Pharma USA from its New Jersey location, but is made in India.*

erlotinib-fig2 - erlotinib fig2

erlotinib-fig2 - erlotinib fig2

This is a chart showing the survival probability and overall survival of patients who were treated with placebo or Erlotinib over a period of time. The chart also provides the number of patients at risk in each category.*

erlotinib-fig3 - erlotinib fig3

erlotinib-fig3 - erlotinib fig3

erlotinib-fig4 - erlotinib fig4

erlotinib-fig4 - erlotinib fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (30 Tablets Bottle) - erlotinib fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (30 Tablets Bottle) - erlotinib fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (30 Tablets Carton) - erlotinib fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (30 Tablets Carton) - erlotinib fig6

This is a unit-dose package of Erlotinib tablets containing 25mg of erlotinib free base. The package contains 10 (1x10) unit-dose tablets intended for prescription use only. The tablets should be stored at 20-25°C and not child-resistant. The distributor of the package is Aurobindo Pharma USA, Inc. The package also contains Dosage and Administration instructions which refers to an enclosed package insert for further information. The text "Over Printing Zone" appears at the top of the package.*

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL- 100 mg (30 Tablets Bottle) - erlotinib fig7

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL- 100 mg (30 Tablets Bottle) - erlotinib fig7

NDC 59651-531-03 is a prescription drug called Erlotinib Tablets. Each film-coated tablet contains 100 mg of erltinib fres base. The enclosed package insert provides complete prescribing information. It is distributed by Aurobindo Pharma USA, Inc. and made in India. The recommended storage temperature is 20 to 25 degrees Celsius.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (30 Tablets Carton) - erlotinib fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (30 Tablets Carton) - erlotinib fig8

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL- 150 mg (30 Tablets Bottle) - erlotinib fig9

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL- 150 mg (30 Tablets Bottle) - erlotinib fig9

Erlotinib Tablets are distributed by Aurobindo Pharma USA, Inc. Each coated tablet contains 150mg of erlotinib free base. The package insert for codes TSDRUGS 2472015 should be consulted. The tablets should be stored between 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The medication is only available with a prescription. The provided text does not include non-English characters.*

Chemical Structure - erlotinib str

Chemical Structure - erlotinib str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.